WMIS Podcast

MIB Meet the Authors: Curiosity, Collaboration, and a Zebrafish Discovery

In this episode of the WMIS Podcast, Molecular Imaging and Biology Editor-in-Chief Kimberly Kelly, PhD, speaks with Erik Shapiro, PhD, WMIC 2026 Program Chair, and his daughter Josie Shapiro about their experience publishing a paper together in Molecular Imaging and Biology. They share how a winter-break zebrafish imaging experiment became the study “Go Fish,” which examined the uptake of clinical hepatospecific MRI contrast agents and uncovered an unexpected similarity between zebrafish and humans. The conversation also explores scientific creativity, troubleshooting, the value of learning from failed experiments, and the importance of making science accessible beyond the laboratory. Erik also reflects on MIB as a home for the molecular imaging community and offers a look ahead at WMIC 2026.

• Transcript

MIB Conversations: WMIS Presidential Candidate Jim Delikatny

In this episode of MIB Conversations, Molecular Imaging and Biology Editor-in-Chief Kimberly Kelly sits down with Jim Delikatny, a candidate for President of the World Molecular Imaging Society (WMIS). Jim discusses his career in optical and fluorescence imaging, the translation of new imaging technologies toward clinical care, and the importance of innovation across the field. He also shares his perspective on supporting early-career scientists, strengthening partnerships with industry and regulatory agencies, encouraging entrepreneurship, and expanding opportunities for the molecular imaging community. This episode is part of a special MIB Conversations series featuring each of the candidates for WMIS President. All three candidates were invited to participate in individual conversations with Kim Kelly so members can hear directly from them about their science, experience, priorities, and perspectives.

• Transcript

MIB Conversations: WMIS Presidential Candidate Michelle James

In this episode of MIB Conversations, Molecular Imaging and Biology Editor-in-Chief Kimberly Kelly sits down with Michelle James, a candidate for President of the World Molecular Imaging Society (WMIS). Michelle discusses her work using molecular imaging to better understand the immune system in neurological disease and to make previously invisible biological processes visible for patients. The conversation also explores scientific discovery, mentorship, patient-focused research, and Michelle’s perspective on building a more global, inclusive, innovative, and connected molecular imaging community. This episode is part of a special MIB Conversations series featuring each of the candidates for WMIS President. All three candidates were invited to participate in individual conversations with Kim Kelly so members can hear directly from them about their science, experience, priorities, and perspectives.

• Transcript

MIB Conversations: WMIS Presidential Candidate Jeff Bulte

In this episode of MIB Conversations, Molecular Imaging and Biology Editor-in-Chief Kimberly Kelly sits down with Jeff Bulte, a candidate for President of the World Molecular Imaging Society (WMIS). Jeff discusses his career in molecular imaging, his commitment to mentorship and scientific communication, and the importance of collaboration across disciplines. The conversation explores emerging technologies including magnetic particle imaging (MPI), cell tracking, and CEST MRI, as well as Jeff’s perspective on the future of molecular imaging and the scientific community. This episode is part of a special MIB Conversations series featuring each of the candidates for WMIS President. All three candidates were invited to participate in individual conversations with Kim Kelly so members can hear directly from them about their science, experience, priorities, and perspectives.

• Transcript

MIB: From Discovery to Patient Care - Advancing Molecular Imaging Through Research and Community

In this episode of the WMIS Podcast, host Kimberly Kelly, PhD, speaks with Anna Moore, PhD, current President of the World Molecular Imaging Society and a longtime Section Editor for Molecular Imaging and Biology. Dr. Moore reflects on her career in molecular imaging, from her early research at Massachusetts General Hospital and Harvard Medical School to developing nanoparticle-based therapeutics now being evaluated in clinical trials. They also discuss the role of Molecular Imaging and Biology in advancing the field, the value of constructive peer review, and the emerging approaches shaping the future of translational research.

• Transcript

MIB Meet the Editors: Natasha Sheybani on Focused Ultrasound, Mentorship, and Publishing

Molecular Imaging & Biology Editor-in-Chief Kimberly Kelly welcomes Senior Section Editor Natasha Sheybani for a conversation about her journey from graduate student to faculty member, developing an independent scientific vision, securing competitive funding, and advancing research in focused ultrasound and cancer immunotherapy. They also discuss mentorship, the transition to independence, and the editorial process, including what makes a strong submission to Molecular Imaging & Biology.

• Transcript

Beyond PSMA: Expanding the Theranostic Horizon

PSMA-targeted radiopharmaceuticals have brought theranostics into the clinical spotlight—but what comes next? In this episode, host Dr. Mike Nickels is joined by Dr. Anna Wu (City of Hope) for a wide-ranging discussion on the future of theranostics beyond PSMA. Together, they explore what makes a strong theranostic target, how evolving tumor biology and heterogeneity are shaping next-generation agents, and why pan-cancer and tumor-microenvironment targets are gaining momentum. The conversation also dives into combination strategies, alpha-emitters, clinical translation challenges, and what the next decade may hold for the field. A must-listen for scientists, clinicians, and anyone interested in where theranostics is headed next.

Global Access & Innovation, Part 1: A Conversation on Point-of-Care Technologies in Molecular Imaging

Host Arvind Pathak, PhD (Johns Hopkins University) speaks with Rebecca Richards-Kortum, PhD (Rice University) about how point-of-care technologies are expanding access to early detection and diagnosis in low-resource settings. They discuss innovations in optical imaging, the role of machine learning, real-world lessons from cervical cancer screening programs, and why sustainable training and local partnerships are essential for global impact.

Canada’s Nuclear Leadership in Isotopes

This special episode, produced in collaboration with the Canadian Nuclear Isotope Council (CNIC), features James Scongack - the CNIC’s Chair and COO of Bruce Power - discussing Canada’s global leadership in medical isotope production. From cobalt-60 to lutetium-177, learn how Canada is investing in infrastructure, building cross-border partnerships, and scaling up to meet the growing demand for radiotheranostics.

Isotope Supply: Can Theranostics Scale?

In this episode, Dr. Cathy Cutler of Brookhaven National Lab joins host Dr. Mike Nickels to explore one of the most pressing questions in nuclear medicine today: can theranostics scale? From supply chain challenges for key isotopes like Lu-177, Ac-225, and Cu-67 to infrastructure gaps, regulatory hurdles, and international collaboration, this wide-ranging conversation highlights both the urgency and opportunity in building a robust isotope supply for the future of targeted radiopharmaceutical therapy.

Theranostics in the Clinic: What’s Working, What’s Missing, and What’s Next

In this episode, Dr. Lilja Solnes (Johns Hopkins) and Dr. Martin Pomper (UT Southwestern) explore the current landscape of theranostics in clinical practice, from the early days of targeted radiopharmaceuticals to today’s breakthroughs and future directions. They discuss the success of agents like Lutathera and Pluvicto, the importance of preclinical models, the rise of alpha emitters, and the potential of combination therapies. With candid reflections on what’s working, what’s missing, and how to bridge the gap between research and patient care, this conversation offers deep insights into the evolving role of molecular imaging and therapy.

Alpha Therapy: Opportunities, Challenges, and Clinical Impact

In this episode, host Dr. Mike Nickels welcomes nuclear medicine pioneer Dr. Richard Wahl for an in-depth exploration of alpha-emitting radiopharmaceuticals. Learn where alpha therapy holds the most clinical promise, and what’s needed to bring these powerful agents into routine care. From supply chain hurdles to toxicity management and future clinical applications, this conversation offers expert insight into one of the most exciting—and complex—frontiers in nuclear medicine.

Theranostics Unpacked: Precision, Promise, and the Future of Nuclear Medicine

In this inaugural episode of the WMIS Podcast, Dr. Mike Nickels sits down with Dr. Diane Abou of NorthStar Medical Radioisotopes for a dynamic conversation about the rise of theranostics in nuclear medicine. Tune in as they unpack what theranostics really means, why it’s gaining momentum, and how it's transforming the future of patient care. Learn about clinical applications, key challenges in isotope production, and why this is such an exciting time for the field.